nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acquired haemophilia A, concomitant acute myocardial infarction and urgent major surgery: How to successfully treat a critical patient with rpFVIII (Obizur®)
|
Zanon, Ezio |
|
|
195 |
C |
p. 125-127 |
artikel |
2 |
Activated prothrombin complex concentrates for direct oral anticoagulant-associated bleeding or urgent surgery: Hemostatic and thrombotic outcomes
|
Shaw, Joseph R. |
|
|
195 |
C |
p. 21-28 |
artikel |
3 |
A diagnosis of atrial fibrillation is not a predictor for pulmonary embolism
|
Friberg, Leif |
|
|
195 |
C |
p. 238-242 |
artikel |
4 |
A fortune teller's dream or clinician's nightmare: Right ventricular assessment for risk prediction in pulmonary embolism
|
Piazza, Gregory |
|
|
195 |
C |
p. 169-170 |
artikel |
5 |
A multicenter reference interval study of thromboelastography in the Chinese adult population
|
Zeng, Xianfei |
|
|
195 |
C |
p. 180-186 |
artikel |
6 |
Antithrombotic “in vivo” effects of quercetin 3,7,3’,4’-tetrasulfate isolated from Flaveria bidentis in an experimental thrombosis model in mice
|
Guglielmone, Hugo A. |
|
|
195 |
C |
p. 190-192 |
artikel |
7 |
Applying rigorous eligibility criteria to studies evaluating prognostic utility of serum biomarkers in pulmonary embolism: A systematic review and meta-analysis
|
Nithianandan, Harrish |
|
|
195 |
C |
p. 195-208 |
artikel |
8 |
Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients?
|
Siguret, Virginie |
|
|
195 |
C |
p. 74-76 |
artikel |
9 |
Assessment of rotational thrombelastometry (ROTEM) parameters in hepatocellular carcinoma
|
Seeßle, Jessica |
|
|
195 |
C |
p. 55-57 |
artikel |
10 |
A systematic review on the efficacy and safety of low molecular weight heparin as an anticancer therapeutic in preclinical animal models
|
Ripsman, David |
|
|
195 |
C |
p. 103-113 |
artikel |
11 |
Biallelic variants in PROZ as a cause of hypercoagulability and livedo racemosa
|
Pinto e Vairo, Filippo |
|
|
195 |
C |
p. 187-189 |
artikel |
12 |
Coronavirus disease 2019 (COVID-19) associated coagulopathy and its impact on outcomes in Shenzhen, China: A retrospective cohort study
|
Luan, Ying-yi |
|
|
195 |
C |
p. 62-68 |
artikel |
13 |
Correlation of indirect markers of hypercoagulability with thromboelastography in severe coronavirus 2019
|
Hightower, Stephanie |
|
|
195 |
C |
p. 69-71 |
artikel |
14 |
Covid-19 associated autoimmune thrombotic thrombocytopenic purpura: Report of a case
|
Hindilerden, Fehmi |
|
|
195 |
C |
p. 136-138 |
artikel |
15 |
D-dimer level is associated with the severity of COVID-19
|
Yu, Hai-Han |
|
|
195 |
C |
p. 219-225 |
artikel |
16 |
Determinants of left atrial thrombus or spontaneous echo contrast in nonvalvular atrial fibrillation
|
Han, Deheng |
|
|
195 |
C |
p. 233-237 |
artikel |
17 |
Diagnostic performance of coagulation indices for direct oral anticoagulant concentration
|
Zhang, Hanxu |
|
|
195 |
C |
p. 171-179 |
artikel |
18 |
Editorial Board
|
|
|
|
195 |
C |
p. IFC |
artikel |
19 |
Erythrocyte-rich thrombi related to serum iron contribute to single stent retrieval and favorable clinical outcomes in acute ischemic stroke by endovascular treatment
|
Liu, Mingli |
|
|
195 |
C |
p. 8-15 |
artikel |
20 |
Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care
|
Thomas, W. |
|
|
195 |
C |
p. 226-227 |
artikel |
21 |
Immature platelets: a review of the available evidence
|
Benlachgar, Naoufal |
|
|
195 |
C |
p. 43-50 |
artikel |
22 |
Incidence and prevalence of venous thromboembolism in Norway 2010–2017
|
Ghanima, Waleed |
|
|
195 |
C |
p. 165-168 |
artikel |
23 |
Increased levels of platelet-derived microparticles in pulmonary hypertension
|
Ogawa, Aiko |
|
|
195 |
C |
p. 120-124 |
artikel |
24 |
Innate coagulability changes with age in stored packed red blood cells
|
Pulliam, Kasiemobi E. |
|
|
195 |
C |
p. 35-42 |
artikel |
25 |
In vitro hemocompatibility testing of medical devices
|
Nalezinková, Martina |
|
|
195 |
C |
p. 146-150 |
artikel |
26 |
Longitudinal analysis of extracellular vesicle-associated tissue factor activity in cancer patients
|
Reitter, Eva-Maria |
|
|
195 |
C |
p. 215-218 |
artikel |
27 |
Management and outcomes of cancer patients with venous thromboembolism presenting with thrombocytopenia
|
Lecumberri, Ramón |
|
|
195 |
C |
p. 139-145 |
artikel |
28 |
Management of high-risk pulmonary embolism in an “unstable medical environment”: Not only a matter of hemodynamic
|
Zuin, Marco |
|
|
195 |
C |
p. 193-194 |
artikel |
29 |
Novel assay based on diluted prothrombin time reflects anticoagulant effects of direct oral factor Xa inhibitors: Results of multicenter study in Japan
|
Ieko, Masahiro |
|
|
195 |
C |
p. 158-164 |
artikel |
30 |
Observational study of recombinant factor VIII-Fc, rFVIIIFc, in hemophilia A
|
Ebbert, Patrick T. |
|
|
195 |
C |
p. 51-54 |
artikel |
31 |
Predicting bleeding risk by simplified PRECISE-DAPT score
|
Choi, Sun Young |
|
|
195 |
C |
p. 72-73 |
artikel |
32 |
Pulmonary embolism in hospitalised patients with COVID-19
|
Whyte, Martin B. |
|
|
195 |
C |
p. 95-99 |
artikel |
33 |
Recurrent venous thromboembolism during anticoagulation with edoxaban or warfarin: A post hoc analysis of the Hokusai-VTE trial
|
Eichinger, Sabine |
|
|
195 |
C |
p. 209-214 |
artikel |
34 |
Rewarming from accidental hypothermia enhances whole blood clotting properties in a murine model
|
Horioka, Kie |
|
|
195 |
C |
p. 114-119 |
artikel |
35 |
Right ventricular stroke distance predicts death and clinical deterioration in patients with pulmonary embolism
|
Yuriditsky, Eugene |
|
|
195 |
C |
p. 29-34 |
artikel |
36 |
Safety and efficacy of drug eluting stents vs bare metal stents in patients with atrial fibrillation: A systematic review and meta-analysis
|
Sambola, Antonia |
|
|
195 |
C |
p. 128-135 |
artikel |
37 |
Small procoagulant platelets in diabetes type 2
|
Edvardsson, Maria |
|
|
195 |
C |
p. 1-7 |
artikel |
38 |
Switch to direct anticoagulants and improved endothelial function in patients with chronic heart failure and atrial fibrillation
|
Correale, Michele |
|
|
195 |
C |
p. 16-20 |
artikel |
39 |
TFPIα alleviated vascular endothelial cell injury by inhibiting autophagy and the class III PI3K/Beclin-1 pathway
|
Zhao, Yong |
|
|
195 |
C |
p. 151-157 |
artikel |
40 |
The antithrombotic effect of caffeic acid is associated with a cAMP-dependent pathway and clot retraction in human platelets
|
Nam, Gi Suk |
|
|
195 |
C |
p. 87-94 |
artikel |
41 |
The increased risk of bleeding due to drug-drug interactions in patients administered direct oral anticoagulants
|
Lee, Ji Yun |
|
|
195 |
C |
p. 243-249 |
artikel |
42 |
The reversed halo sign: Considerations in the context of the COVID-19 pandemic
|
Marchiori, Edson |
|
|
195 |
C |
p. 228-230 |
artikel |
43 |
Thrombophilia testing in patients receiving rivaroxaban or apixaban for the treatment of venous thromboembolism
|
Kovacs, Matthew R. |
|
|
195 |
C |
p. 231-232 |
artikel |
44 |
Thromboprophylaxis after renal transplantation and patient risk stratification: The case of mTOR inhibitors
|
Jara-Palomares, Luis |
|
|
195 |
C |
p. 100-102 |
artikel |
45 |
Timing of parenteral anticoagulation after thrombolysis for the treatment of pulmonary embolism
|
Schwab-Daugherty, Elyse M. |
|
|
195 |
C |
p. 58-61 |
artikel |
46 |
Venous thromboembolism after fast-track unicompartmental knee arthroplasty – A prospective multicentre cohort study of 3927 procedures
|
Petersen, Pelle Baggesgaard |
|
|
195 |
C |
p. 81-86 |
artikel |
47 |
Von Willebrand factor, ABO blood group, and risk of first-ever intracerebral hemorrhage: A prospective nested case-control study
|
Johansson, Kristina |
|
|
195 |
C |
p. 77-80 |
artikel |